Cargando…

Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models

Whole-exome sequencing of Parkinson’s disease (PD) patient DNA identified single-nucleotide polymorphisms (SNPs) in the tyrosine nonreceptor kinase-2 (TNK2) gene. Although this kinase had a previously demonstrated activity in preventing the endocytosis of the dopamine reuptake transporter (DAT), a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nourse, J. Brucker, Russell, Shannon N., Moniz, Nathan A., Peter, Kylie, Seyfarth, Lena M., Scott, Madison, Park, Han-A, Caldwell, Kim A., Caldwell, Guy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963946/ https://www.ncbi.nlm.nih.gov/pubmed/36745808 http://dx.doi.org/10.1073/pnas.2210712120

Ejemplares similares

Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans
por: Gaeta, Anthony L., et al.
Publicado: (2022)

Attenuation of Dopaminergic Neurodegeneration in a C. elegans Parkinson’s Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2
por: Starr, Lindsey A., et al.
Publicado: (2023)

Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress
por: Nourse, J. Brucker, et al.
Publicado: (2021)

Functional Modulators of Resilience to Age-Associated Dopaminergic Neurodegeneration in C. elegans
por: Caldwell, Guy
Publicado: (2020)

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
por: Yacoubian, T A, et al.
Publicado: (2010)

Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease
por: Gaeta, Anthony L., et al.
Publicado: (2023)

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson’s Disease
por: Gaeta, Anthony L., et al.
Publicado: (2019)

Xanthine Dehydrogenase Is a Modulator of Dopaminergic Neurodegeneration in Response to Bacterial Metabolite Exposure in C. elegans
por: Thies, Jennifer L., et al.
Publicado: (2023)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson’s models
por: Kim, Hanna, et al.
Publicado: (2018)

No Country for Old Worms: A Systematic Review of the Application of C. elegans to Investigate a Bacterial Source of Environmental Neurotoxicity in Parkinson’s Disease
por: Caldwell, Kim A., et al.
Publicado: (2018)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease
por: Wang, Yanqin, et al.
Publicado: (2017)

Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration
por: Caldwell, Kim A., et al.
Publicado: (2009)

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
por: Nguyen, An Phu Tran, et al.
Publicado: (2020)

ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans
por: Griffin, Edward F., et al.
Publicado: (2019)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: He, Xin, et al.
Publicado: (2021)

Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson’s Disease
por: Javed, Hayate, et al.
Publicado: (2019)

Epigenetic modification in Parkinson’s disease
por: Song, Hao, et al.
Publicado: (2023)

The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice
por: Dong, Qiaoyun, et al.
Publicado: (2015)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
por: Ahuja, Manuj, et al.
Publicado: (2021)

Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson’s Disease
por: Wang, Shaoxiao, et al.
Publicado: (2016)

Neuroprotective Effects of Tetramethylpyrazine against Dopaminergic Neuron Injury in a Rat Model of Parkinson's Disease Induced by MPTP
por: Lu, Chen, et al.
Publicado: (2014)

Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
por: Harrison, Ian F., et al.
Publicado: (2016)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2017)

Voltage-Gated Ca(2+) Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?
por: Ortner, Nadine J.
Publicado: (2021)

CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
por: Saraiva, Cláudia, et al.
Publicado: (2023)

Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line
por: Al-Zaid, Felwah S., et al.
Publicado: (2023)

Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons
por: Dolga, A M, et al.
Publicado: (2014)

Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model
por: Ray, A, et al.
Publicado: (2014)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Dopaminergic brainstem disconnection is common to pharmacological and pathological consciousness perturbation
por: Spindler, Lennart R. B., et al.
Publicado: (2021)

Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons
por: Cronin, Shane J. F., et al.
Publicado: (2023)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP
por: Viveros-Paredes, Juan M., et al.
Publicado: (2017)

Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
por: D’Amico, Ramona, et al.
Publicado: (2022)

Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression
por: Orme, Rowan P., et al.
Publicado: (2013)

The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity
por: Kim, Hanna, et al.
Publicado: (2018)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7slc6t5o1f2rgr9dnd5qokva86